← FDA DRUG APPROVALS

FDA ANDA · ANDA088317

NANDROLONE DECANOATE

Sponsor: ABRAXIS PHARM

APPLICATION
ANDA088317
TYPE
ANDA
ORIGINAL APPROVAL
1983-10-14
LATEST ACTION
1991-02-04
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NANDROLONE DECANOATEDiscontinued
NANDROLONE DECANOATE 200MG/ML · INJECTABLE · INJECTION

Approval history

1991-02-04Labeling · Supplement 14AP
1988-02-18Labeling · Supplement 10AP
1983-10-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →